… diagnostic methods at clinical sites is plagued by many caveats including availability and
access. This review surveys new diagnostic methods … regard to dementia diagnosis at clinical …

… diagnostics of neurodegenerative dementias have been introduced (see Figure 1). In this
review, … on the most promising methods for diagnostics, ie, SIMOA and RT-QuIC (see Table 1). …

… This review summarizes the importance of … cause of dementia and is thought to account for
60–80% of dementia cases (3). Currently, the total annual cost for AD and other dementias in …

… Alzheimer's disease (AD) and other dementias are a global challenge. Early diagnosis is
important to manage the disease… The differential diagnosis of AD from other dementias is …

… low diagnostic specificity has been related to other dementias [14]. Recent studies have
suggested that AD begins decades before the onset of clinical symptoms of dementia through …

… The development of in-vivo biomarkers has moved the diagnosis of Alzheimer's disease
from the dementia stage towards the prodromal stage, and has introduced the potential for …

… , and Aβ40) in dementias other than AD, and in particular in DLB patients. We have … this
disease is of great importance. Thus, this review will look at all biomarkers other than Alzheimer’…

… appropriate use of [F-18]FDG PET for clinical dementia workup. PET images with [F-18]FDG …
Alzheimer's disease (AD), Dementia with Lewy bodies (DLB), and frontotemporal dementia (…

… Here, we provide an overview of the biomarkers that reflect the core components of AD …
dementias, eg, progressive supranuclear palsy and some forms of frontotemporal dementia [23]. …

… Our aim is not to provide an exhaustive review of the available evidence on the utility of
PET imaging in dementia. Instead, we provide a consensual assessment of the optimal use of …